Sotera Health Company · 12 hours ago
Financial Analyst - Internship
Sotera Health Company is a leading global provider of mission-critical sterilization and lab testing and advisory services for the healthcare industry. They are seeking Finance Interns to support financial operations, engage in real project work, and gain hands-on experience in corporate finance over a 12-week program.
BiotechnologyHealth CareMedical Device
Responsibilities
Assist in preparing recurring financial reports, including variance analyses and monthly close activities
Collect, organize, and analyze financial data to support decision-making
Help maintain accuracy of financial dashboards and performance metrics
Contribute to the preparation of annual budgets and quarterly forecasts
Compile relevant departmental inputs and validate data accuracy
Run scenario analyses and identify key assumptions or risks
Support cost-tracking efforts and assist in identifying cost-saving opportunities
Analyze trends related to operating expenses, project spending, and resource utilization
Assist in basic margin and profitability reviews across service areas
Prepare materials for financial reviews with business leaders
Help respond to financial inquiries from internal stakeholders with timely data and insights
Coordinate documentation, follow-up items, and action tracking from finance meetings
Participate in finance projects such as system enhancements, process improvements, or workflow standardization
Assist in creating tools, templates, or models that improve reporting efficiency
Collaborate with cross-functional teams to ensure project deliverables are met
Qualification
Required
College student majoring in a finance-centric degree: Finance, Accounting, Economics, Business Administration, or related fields
Company
Sotera Health Company
Sotera Health brings together Sterigenics, Nelson Labs and Nordion, each of which are established, highly reputable players in the global health arena.
Funding
Current Stage
Public CompanyTotal Funding
$3.3B2024-05-30Post Ipo Debt· $2.26B
2024-02-28Post Ipo Secondary· $368.75M
2021-03-17Post Ipo Secondary· $675M
Leadership Team
Recent News
2026-01-07
2025-12-18
Company data provided by crunchbase